Join the conversation around treatment and research in Oncology. This website is intended for HCPs outside the US and the UK.
http://www.inoncology.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
1.1 seconds
16x16
32x32
Boehringer Ingelheim International GmbH
3460-02-06 Corporate Department Trademarks
Binger●●●●●●se 173
Ing●●●eim , D - 55216
DE
View this contact
Boehringer Ingelheim GmbH
3344-EG-04 I*Net Solution Center
Abteilung I●●●●●●●●●●●erarbeitung
Ing●●●eim , Rhineland-Palatinate, D-55216
DE
View this contact
CSC Corporate Domains, Inc.
DNS Administrator
2711 Ce●●●●●●●lle Rd.
Wil●●●ton , DE, 19808
US
View this contact
BUY YOUR DOMAIN
14
YEARS
5
MONTHS
23
DAYS
CSC CORPORATE DOMAINS, INC.
WHOIS : whois.corporatedomains.com
REFERRED : http://www.cscglobal.com
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
26
SITE IP
77.246.39.195
LOAD TIME
1.089 sec
SCORE
6.2
InOncology | Oncology Investigation, Research and Treatment Options | Boehringer Ingelheim | inoncology.com Reviews
https://inoncology.com
Join the conversation around treatment and research in Oncology. This website is intended for HCPs outside the US and the UK.
letscollaborate.inoncology.com
Let's Learn in Oncology, collaborative medical education from Boehringer Ingelheim
Flyout claim - Lorem ipsum dol amete. Welcome to the Boehringer Ingelheim Oncology medical education portal on ESMO Oncology PRO. Here, you can find recent highlights from the medical education initiatives of Boehringer Ingelheim Oncology, with a focus on Lung Cancer and Targeted Therapies. As a main sponsor of ESMO Oncology Pro, Boehringer Ingelheim is pleased to be able to provide medical education that ESMO Oncology PRO members can access exclusively through this portal.
研究与开发
http://www.boehringer-ingelheim.cn/yanjiuyukaifa.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation. No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player.
Afatinib (Giotrif) auf oncotrends.de
http://www.oncotrends.de/wirkstoffe/afatinib-giotrif
08092016 Neue Analyse bestätigt gleich bleibende Wirksamkeit von GIOTRIF (Afatinib) nach verträglichkeitsbedingter Dosisanpassung bei Patienten mit fortgeschrittenem NSCLC und aktivierenden EGFR-Mutationen. 13062016 Boehringer Ingelheim startet ELUXA-Studienprogramm zur Untersuchung des vielversprechenden Lungenkrebs-Präparats Olmutinib. 11042016 GIOTRIF (Afatinib) jetzt in Europa als neue orale Therapieoption …. 18082015 Afatinib: Zusatznutzen bei bestimmten Mutationen bestätigt. Afatinib* ist der erste...
Sponsorship & Exhibition
http://www.lalca2014.org/sponsorship-a-exhibition/sponsorship
Groups (10 or more). Social Events and Tours. Pre- and Post Tours. Travel and Visa Information. Join the Mailing List. This is an exciting time for lung cancer professionals from Latin America and around the world to share the most up-to-date information regarding the science and advances in the treatment of lung cancer and the 6th Latin American Lung Cancer Conference (LALCA 2014). Taking place August 21 - 23, 2014. At the Westin Lima Hotel and Convention Center in Lima, Peru. Aurora, Colorado 80011.
LUX-Lung 3 Clinical Trial | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/first_line_efficacy_and_safety/pfs.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Demonstrated su...
EGFR Mutations & Biomarker Testing | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/egfr_testing/incidence.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Based on multip...
EGFR Mutations & Biomarker Testing | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/egfr_testing/Guidelines-on-Testing.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Based on multip...
LUX-Lung 3 Clinical Trial | GIOTRIF® (afatinib)
https://www.giotrif.com/healthcare_professionals/first_line_efficacy_and_safety/os.html
Skip to main content. GIOTRIF (afatinib) as monotherapy is indicated for the treatment of: Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s); locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy. For more information please see the EU Summary of Product Characteristics. See countries where GIOTRIF. 1st Line EGFR M. Demonstrated su...
TOTAL LINKS TO THIS WEBSITE
26
inoncable.com
The domain inoncable.com is for sale. To purchase, call Afternic.com at 1 781-373-6847 or 855-201-2286. Click here for more details.
inoncence's blog - inocence - Skyrock.com
Châlons en champagne (51). 13/07/2011 at 7:17 AM. 24/07/2011 at 5:42 AM. Subscribe to my blog! Don't forget that insults, racism, etc. are forbidden by Skyrock's 'General Terms of Use' and that you can be identified by your IP address (66.160.134.11) if someone makes a complaint. Please enter the sequence of characters in the field below. Posted on Sunday, 24 July 2011 at 5:42 AM. Bonjour je me prenome inocence par ce que je suis une personne sens histoire et c pas aujourd'huit que j'en veu.
Blog de inoncent - sky nandite - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Mise à jour :. Abonne-toi à mon blog! Cheikh niane et modou. Ce sont mes amis. Il sont tres coollllllllllllllllll. N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (67.219.144.114) si quelqu'un porte plainte. Ou poster avec :. Retape dans le champ ci-dessous la suite de chiffres et de lettres qui apparaissent dans le cadre ci-contre.
inonco.com - IT- Consulting and more..
Bitte haben Sie dafür Verständnis, dass unsere Internetpräsenz zur Zeit überarbeitet wird. Info a t inonco.com. Fax: 0180 - 3663388 - 02329 (0.09 / Minute Brutto). Umsatzsteuer-Identifikationsnummer gemäß 27 a Umsatzsteuergesetz: DE255795333.
InOncology | Oncology Investigation, Research and Treatment Options | Boehringer Ingelheim
WELCOME TO THE INONCOLOGY WEBSITE FOR INTERNATIONAL HEALTHCARE PROFESSIONALS OUTSIDE THE UNITED STATES OF AMERICA AND THE UNITED KINGDOM. This website is an international information resource intended for international healthcare professionals outside the United States of America (US) and the United Kingdom (UK) who are interested in information about Boehringer Ingelheim oncology. By clicking on the link below you are declaring and confirming that you are a healthcare professional outside the United Sta...
InOncology.es | El portal de Boehringer Ingelheim sobre oncología
ACCEDE A NUESTRO PORTAL. ACCEDE A NUESTRO PORTAL. Soy paciente / cuidador. Inoncology 2014. Todos los derechos reservados. Esta página Web utiliza Cookies propias y de terceros para mejorar nuestros servicios y analizar los hábitos de navegación del usuario. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración de cookies u obtener más información visitando nuestra Política de Cookies.
Boehringer Ingelheim oncology research, trials & products | InOncology
Jump to main navigation. Jump to meta navigation. Kattintson a havi inoncology közvélemény-kutatásban való részvételhez, és hasonlítsa össze válaszait más egészségügyi szakemberekével. Ugrás a lap tetejére. Boehringer Ingelheim International GmbH. Minden jog fenntarva. Thank you for your visit. You have successfully logged out. Back to login.
INON Consulting
Mission, Vision and Values. INON Consulting is your bridge between strategy and execution. Primary mission is to support business leaders and their teams as they pursue success in the four must win areas of business: People. In achieving our primary mission, we generate revenue to pursue our secondary mission of redeploying earnings to fund non-profit initiatives we believe in (providing food, clothing and shelter to those in need). Was formed to solve this problem. We become your special ops team fo...
inond
Our website is still being built at the moment. But you can still contact us, email someone@inond.com.
Inond.fr
As Malick and Blue Tribe. Kdr Color,graffiti artiste pro. Visite Virtuelle – Big Jam Graffiti 2015-. 50 rue Oberlin nancy. Cabane festival de Moselle 2015. Artiste hiphop de Nancy, sortie du clip John Koffy. Sortie de l’album des Kalkanos,. Place de la comédie 57000 metz. Exposition, Ces Animaux Qu’on Mange, à Nancy en Lorraine. 34 rue sainte catherine nancy. Les annonces en news. Concert de Vladimir Cosma. Espace Montrichard 54700 Pont à Mousson. Concert de Eric Serra, à Pont a Mousson, Lorraine.
